1. Cullingford TE. Molecular regulation of ketogenesis.
In: Stafstrom CE, Rho JM, eds. Epilepsy and the Ketogenic
Diet. Totowa, NJ: Humana; 2004:201-215.
2. Hartman AL, Vining EP. Clinical aspects of the ketogenic
diet. Epilepsia. 2007;48(1):31-42.
3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N
Engl J Med. 2000;342(5):314-319.
4. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly
LM. The efficacy of the ketogenic diet-1998: a prospective evaluation
of intervention in 150 children. Pediatrics. 1998;102(6):1358-1363.
5. Vining EP, Freeman JM, Ballaban-Gil K, et al. A multicenter study
of the efficacy of the ketogenic diet. Arch Neurol. 1998;55(11):1433-1437.
6. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade
later. Pediatrics. 2007;119(3):535-543.
7. Kinsman SL, Vining EP, Quaskey SA, Mellits D, Freeman JM. Efficacy
of the ketogenic diet for intractable seizure disorders: review
of 58 cases. Epilepsia. 1992;33(6):1132-1136.
8. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet
for the treatment of childhood epilepsy: a randomised controlled
trial. Lancet Neurol. 2008;7(6):500-506.
9. Stainman RS, Turner Z, Rubenstein JE, Kossoff EH. Decreased relative
efficacy of the ketogenic diet for children with surgically approachable
epilepsy. Seizure. 2007;16(7):615-619.
10. Than KD, Kossoff EH, Rubenstein JE, Pyzik PL, McGrogan JR, Vining
EP. Can you predict an immediate, complete, and sustained response
to the ketogenic diet? Epilepsia. 2005;46(4):580-582.
11. Kossoff EH, Laux LC, Blackford R, et al. When do seizures usually
improve with the ketogenic diet? Epilepsia. 2008;49(2):329-333.
12. Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic epilepsy:
clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007;48(9):1703-1707.
13. Caraballo RH, Cersosimo RO, Sakr D, Cresta A, Escobal N,
Fejerman N. Ketogenic diet in patients with Dravet syndrome. Epilepsia. 2005;46(9):1539-1544.
14. Nordli DR, Jr., Kuroda MM, Carroll J, et al. Experience
with the ketogenic diet in infants. Pediatrics. 2001;108(1):129-133.
15. Kossoff EH, Pyzik PL, McGrogan JR, Vining EP, Freeman JM.
Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002;109(5):780-783.
16. Kossoff EH, Thiele EA, Pfeifer HH, McGrogan JR, Freeman
JM. Tuberous sclerosis complex and the ketogenic diet. Epilepsia. 2005;46(10):1684-1686.
17. Sirven J, Whedon B, Caplan D, et al. The ketogenic diet
for intractable epilepsy in adults: preliminary results. Epilepsia. 1999;40(12):1721-1726.
18. Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones
and the ketogenic diet: risk factors and prevention. J Child
Neurol. 2007;22(4):375-378.
19. Vining EP, Pyzik P, McGrogan J, et al. Growth of children
on the ketogenic diet. Dev Med Child Neurol. 2002;44(12):796-802.
20. Peterson SJ, Tangney CC, Pimentel-Zablah EM, Hjelmgren B, Booth
G, Berry-Kravis E. Changes in growth and seizure reduction in children
on the ketogenic diet as a treatment for intractable epilepsy. J
Am Diet Assoc. 2005;105(5):718-725.
21. Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the
ketogenic diet in the treatment of epilepsy. Dev Med Child
Neurol. 2006;48(12):978-981.
22. Schwartzkroin PA. Mechanisms underlying the anti-epileptic efficacy
of the ketogenic diet. Epilepsy Res. 1999;37(3):171-180.
23. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic
diet. Epilepsia. 2007;48(1):43-58.
24. Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of
the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61(12):1789-1791.
25. Kossoff EH, Rowley H, Sinha SR, Vining EP. A prospective study
of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008;49(2):316-319.
26. Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized
ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65(11):1810-1812.
27. Ben-Menachem E, Hellstrom K, Verstappen D. Analysis of direct
hospital costs before and 18 months after treatment with vagus nerve
stimulation therapy in 43 patients. Neurology. 2002;59(6
Suppl 4):S44-S47.
28. Boon P, D’Have M, Van Walleghem P, et al. Direct medical
costs of refractory epilepsy incurred by three different treatment
modalities: a prospective assessment. Epilepsia. 2002;43(1):96-102.
29. Wheless JW. Vagus nerve stimulation therapy in pediatric patients:
use and effectiveness. In: Pellock JM, Bourgeois BFD, Dodson WE,
Nordli DR, Jr., Sankar R, eds. Pediatric Epilepsy: Diagnosis
and Therapy. 3rd ed. New York: Demos; 2008:811-827.
30. Rutecki P. Anatomical, physiological, and theoretical basis
for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31(Suppl
2):S1-S6.
31. McLachlan RS. Vagus nerve stimulation for intractable epilepsy:
a review. J Clin Neurophysiol. 1997;14(5):358-368.
32. A randomized controlled trial of chronic vagus nerve stimulation for
treatment of medically intractable seizures. The Vagus Nerve Stimulation
Study Group. Neurology. 1995;45(2):224-230.
33. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation
therapy for partial-onset seizures: a randomized active-control
trial. Neurology. 1998;51(1):48-55.
34. Murphy JV. Left vagal nerve stimulation in children with
medically refractory epilepsy. The Pediatric VNS Study Group. J
Pediatr. 1999;134(5):563-566.
35. Labar D. Vagus nerve stimulation for 1 year in 269 patients
on unchanged antiepileptic drugs. Seizure. 2004;13(6):392-398.
36. Helmers SL, Wheless JW, Frost M, et al. Vagus nerve stimulation
therapy in pediatric patients with refractory epilepsy: retrospective
study. J Child Neurol. 2001;16(11):843-848.
37. Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman
WE. Long-term results with vagus nerve stimulation in children with
pharmacoresistant epilepsy. Seizure. 2006;15(7):491-503.
38. Frost M, Gates J, Helmers SL, et al. Vagus nerve stimulation
in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia. 2001;42(9):1148-1152.
39. Labar D, Murphy J, Tecoma E. Vagus nerve stimulation for
medication-resistant generalized epilepsy. E04 VNS Study Group. Neurology. 1999;52(7):1510-1512.
40. Ng M, Devinsky O. Vagus nerve stimulation for refractory
idiopathic generalised epilepsy. Seizure. 2004;13(3):176-178.
41. Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy
JV. Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr
Neurol. 2001;25(3):213-216.
42. Major P, Thiele EA. Vagus nerve stimulation for intractable epilepsy
in tuberous sclerosis complex.
Epilepsy Behav. 2008;13:357.
[PubMed: 18468492]
43. Smyth MD, Tubbs RS, Bebin EM, Grabb PA, Blount JP. Complications
of chronic vagus nerve stimulation for epilepsy in children. J
Neurosurg. 2003;99(3):500-503.
44. Rychlicki F, Zamponi N, Cesaroni E, et al. Complications
of vagal nerve stimulation for epilepsy in children. Neurosurg
Rev. 2006;29(2):103-107.
45. Malow BA, Edwards J, Marzec M, Sagher O, Fromes G. Effects
of vagus nerve stimulation on respiration during sleep: a pilot study. Neurology. 2000;55(10):1450-1454.
46. Nagarajan L, Walsh P, Gregory P, Stick S, Maul J, Ghosh
S. Respiratory pattern changes in sleep in children on vagal nerve stimulation
for refractory epilepsy. Can J Neurol Sci. 2003;30(3):224-227.
47. Khurana DS, Reumann M, Hobdell EF, et al. Vagus nerve stimulation
in children with refractory epilepsy: unusual complications and
relationship to sleep-disordered breathing. Childs Nerv
Syst. 2007;23(11):1309-1312.